is glp 1 microdosing safe What GLP-1 Microdosing? | Health Matters Why we launched Noom's Microdose

The glucagon-like peptide-1 (GLP-1) analogue Semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

Brook 2024

Because AOD9604 is not FDAapproved and cannot be compounded under current guidance, it is offered only under a strict informed consent framework with full transparency about its investigational status, potential risks, and mixed efficacy data

More studies are needed to assess GLP-1s as a potential therapy for alcohol use disorder

Important medical disclaimers Mechanism of Action: Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that belongs to a class of drugs called incretin mimetics